Tag: Hims & Hers Health Inc

Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

Hims & Hers pulls copycat weight-loss pill after threats of legal action